GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
O

OK Biotech Co 4155.TW · TWD

Health Care · Taiwan Stock Exchange · 🇹🇼 Taiwan

Compare

18.50

+3.35%

Close of 9 Nov 2026, in TWD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About OK Biotech Co

Its shares trade on Taiwan Stock Exchange under the ticker 4155.TW. It has been listed since 30 December 2010. In the fiscal year to 31 December 2025, it reported revenue of TWD 1.56bn and net income of TWD 82.4m. At that date it held total assets of TWD 3.85bn and shareholders' equity of TWD 2.51bn.

OK Biotech Co. Ltd. engages in the manufacture, wholesale, trade, and retail of medical equipment and related homecare medical products. The company is headquartered in Hsinchu, Hsinchu. The company went IPO on 2010-12-30. The firm primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The firm distributes its products principally in Taiwan, other Asian markets and the United States.

Figures and description from our data supplier, not checked against the company's own report.

Company facts

Sector
Health Care
Industry
Health Care Equipment & Supplies
Listed since
30 Dec 2010

Leadership

Pay as last reported

  • Mr. Chia To LaiChairman of the Board, General Manager, since 2017
  • Youci LiuVice Chairman of the Board, since 2022
  • Qizheng HouAssistant General Manager of Finance & Accounting Division, Director, since 2010
  • Qingbiao ChenDirector
  • Shiwan LanDirector
  • Zhengang WangDirector
  • Jinyuan XuDirector
  • Guquan ChenIndependent Director
  • Lifen HeIndependent Director
  • Shiyi LinIndependent Director
  • Jingjun LuIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Hsinchu, Taiwan, with a focus on medical equipment manufacturing.
  • Offers household glucose meters and disposable glucose testing strips for diabetes monitoring.
  • Distributes products in Taiwan, Asian markets, and the United States.

Weaknesses

  • Relies on a narrow product range focused on glucose monitoring.
  • Limited to specific markets including Taiwan, Asia, and the U.S.
  • Dependent on a single industry sector, Health Care.

Opportunities

  • Expanding into new markets beyond current geographic reach.
  • Developing additional medical products to diversify offerings.
  • Increasing demand for diabetes monitoring solutions globally.

Threats

  • Competition from other medical equipment manufacturers in the Health Care sector.
  • Regulatory changes affecting medical device distribution in target markets.
  • Economic downturns impacting healthcare spending in key regions.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.